Shares of 3SBIO (01530) rose more than 7% during the trading session. At the time of writing, the stock is up 5.97%, trading at HK$16.33 with a turnover of HK$578 million.

Latest data from the Hong Kong Stock Exchange shows that on June 8th, Chairman and CEO Lou Jing increased his holdings in 3SBIO by 516,000 shares at an average price of HK$15.2497 per share, involving a total amount of approximately HK$7.8688 million. Following this purchase, his latest shareholding stands at about 534 million shares, representing a 21.03% stake. Analysts have previously noted that the company possesses several strong cash-generating products, including Thypaq, which fuel its research and innovation efforts. The authorization of its project 707 has been secured, which is expected to boost company profits while reducing risk exposure in its global market expansion.